Maintenance treatment with antipsychotic drugs for schizophrenia

Evidence suggests (75 RCTs; n=9145) that maintenance on antipsychotic drugs prevents relapse to a greater extent vs placebo for approximately 2 years follow‐up but must be weighed against their adverse effects. Future studies are required to clarify long‐term morbidity/mortality.

Source:

Cochrane Database of Systematic Reviews